* Tenon Medical Inc TNON.OQ TNON.O is expected to show a
rise
in quarterly revenue when it reports results on May 1
(estimated) for the period ending March 31 2024
* The Los Gatos California-based company is expected to
report a
80.8% increase in revenue to $783 thousand from $433 thousand a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
* LSEG's mean analyst estimate for Tenon Medical Inc is for
a
loss of $1.34 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Tenon
Medical Inc
is $4.50, above its last closing price of $0.74.
This summary was machine generated April 29 at 23:18 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)